These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27836178)

  • 1. Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.
    de Almeida SM; Rotta I; Ribeiro CE; Smith D; Wang R; Judicello J; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neuroimmunol; 2016 Dec; 301():41-48. PubMed ID: 27836178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
    de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
    J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
    de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
    J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi.
    Adewumi OM; Dukhovlinova E; Shehu NY; Zhou S; Council OD; Akanbi MO; Taiwo B; Ogunniyi A; Robertson K; Kanyama C; Hosseinipour MC; Swanstrom R
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):490-500. PubMed ID: 31914800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
    Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
    PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.
    Pérez-Santiago J; Schrier RD; de Oliveira MF; Gianella S; Var SR; Day TR; Ramirez-Gaona M; Suben JD; Murrell B; Massanella M; Cherner M; Smith DM; Ellis RJ; Letendre SL; Mehta SR
    J Neurovirol; 2016 Apr; 22(2):191-200. PubMed ID: 26428514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.
    Calcagno A; Romito A; Atzori C; Ghisetti V; Cardellino C; Audagnotto S; Scarvaglieri E; Lipani F; Imperiale D; Di Perri G; Bonora S
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):187-193. PubMed ID: 27826896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection.
    Sturdevant CB; Joseph SB; Schnell G; Price RW; Swanstrom R; Spudich S
    PLoS Pathog; 2015 Mar; 11(3):e1004720. PubMed ID: 25811757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.
    de Almeida SM; Oliveira MF; Chaillon A; Rotta I; Ribeiro CE; de Pereira AP; Smith D; Letendre S; Ellis RJ
    J Neurovirol; 2018 Dec; 24(6):786-796. PubMed ID: 30194587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
    Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S
    J Neurovirol; 2016 Feb; 22(1):88-92. PubMed ID: 26246357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.
    Suh HS; Lo Y; Choi N; Letendre S; Lee SC
    J Neuroinflammation; 2015 Apr; 12():72. PubMed ID: 25890304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood.
    Ellis RJ; Peterson SN; Li Y; Schrier R; Iudicello J; Letendre S; Morgan E; Tang B; Grant I; Cherner M
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32554630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
    Anderson AM; Muñoz-Moreno JA; McClernon DR; Ellis RJ; Cookson D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Franklin DR; Heaton RK; Grant I; Letendre SL;
    J Infect Dis; 2017 Jan; 215(1):105-113. PubMed ID: 27789723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
    Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
    J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
    Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
    HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.
    Yuan L; Liu A; Qiao L; Sheng B; Xu M; Li W; Chen D
    Biomed Res Int; 2015; 2015():506872. PubMed ID: 25821806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.
    Schnell G; Price RW; Swanstrom R; Spudich S
    J Virol; 2010 Mar; 84(5):2395-407. PubMed ID: 20015984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood-brain barrier damage.
    Bavaro DF; Calamo A; Lepore L; Fabrizio C; Saracino A; Angarano G; Monno L
    Infection; 2019 Jun; 47(3):441-446. PubMed ID: 30649685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy.
    Marra CM; Maxwell CL; Collier AC; Robertson KR; Imrie A
    BMC Infect Dis; 2007 May; 7():37. PubMed ID: 17475004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.